Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Peptic Ulcer

Free Subscription Articles published in J Gastroenterol Hepatol Retrieve available abstracts of 34 articles: HTML format Text format

Single Articles

November 2018
1. ZHENG W, Jiang L, Jia X, Long G, et al
   Analysis of risk factors and development of scoring system to predict severity of upper gastrointestinal bleeding in children.
   J Gastroenterol Hepatol. 2018 Nov 21. doi: 10.1111/jgh.14548.
   PubMed     Text format     Abstract available
   
   
   
2. SARRI GL, Grigg SE, Yeomans ND
   Helicobacter pylori increases the risk of low-dose aspirin ulcers: A meta-analysis.
   J Gastroenterol Hepatol. 2018 Nov 8. doi: 10.1111/jgh.14539.
   PubMed     Text format     Abstract available
   
   
   August 2018
3. YEO YH, Hsu CC, Lee CC, Ho HJ, et al
   Systematic review with network meta-analysis: Effectiveness of therapies for second-line Helicobacter pylori eradication.
   J Gastroenterol Hepatol. 2018 Aug 31. doi: 10.1111/jgh.14462.
   PubMed     Text format     Abstract available
   
   
   
4. SUE S, Shibata W, Sasaki T, Kaneko H, et al
   Randomized Trial of Vonoprazan- Versus PPI-Based Third-Line Triple Therapy With Sitafloxacin for Helicobacter pylori.
   J Gastroenterol Hepatol. 2018 Aug 27. doi: 10.1111/jgh.14456.
   PubMed     Text format     Abstract available
   
   
   
5. WU SC, Chen WT, Muo CH, Hsu CY, et al
   A comparative study of subsequent liver cirrhosis risk in non- helicobacter pylori infected peptic ulcer patients with and without vagotomy: an Asian population cohort study.
   J Gastroenterol Hepatol. 2018 Aug 12. doi: 10.1111/jgh.14440.
   PubMed     Text format     Abstract available
   
   
   
6. MOURAD FH, Leong RW
   Role of hemostatic powders in the management of lower gastrointestinal bleeding: A review.
   J Gastroenterol Hepatol. 2018;33:1445-1453.
   PubMed     Text format     Abstract available
   
   
   July 2018
7. CHO JH, Jeon SR, Kim HG, Jin SY, et al
   Cost-effectiveness of a tailored Helicobacter pylori eradication strategy based on the presence of a 23S ribosomal RNA point mutation that causes clarithromycin resistance in Korean patients.
   J Gastroenterol Hepatol. 2018 Jul 16. doi: 10.1111/jgh.14383.
   PubMed     Text format     Abstract available
   
   
   June 2018
8. ADACHI K, Notsu T, Mishiro T, Yoshikawa H, et al
   Influence of Helicobacter pylori infection on periodontitis.
   J Gastroenterol Hepatol. 2018 Jun 22. doi: 10.1111/jgh.14358.
   PubMed     Text format     Abstract available
   
   
   May 2018
9. AUESOMWANG C, Maneerattanaporn M, Chey WD, Kiratisin P, et al
   Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication.
   J Gastroenterol Hepatol. 2018 May 27. doi: 10.1111/jgh.14292.
   PubMed     Text format     Abstract available
   
   
   
10. MIN YW, Kim Y, Gwak GY, Gu S, et al
    Non-alcoholic fatty liver disease and the development of reflux esophagitis: A cohort study.
    J Gastroenterol Hepatol. 2018;33:1053-1058.
    PubMed     Text format     Abstract available
    
    
    March 2018
11. LU B, Zhang L, Wang J, Wang B, et al
    Empirical treatment of outpatients with gastroesophageal reflux disease with proton pump inhibitors: a survey of Chinese patients (the ENLIGHT Study).
    J Gastroenterol Hepatol. 2018 Mar 25. doi: 10.1111/jgh.14143.
    PubMed     Text format     Abstract available
    
    
    
12. CHOWDHRY M, Shah K, Kemper S, Zekan D, et al
    Proton pump inhibitors are not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
    J Gastroenterol Hepatol. 2018 Mar 7. doi: 10.1111/jgh.14141.
    PubMed     Text format     Abstract available
    
    
    
13. GOH KL
    Lessons Learnt from the Epidemiology of Helicobacter Pylori Infection in Malaysia Jghf Marshall and Warren Lecture 2017.
    J Gastroenterol Hepatol. 2018 Mar 2. doi: 10.1111/jgh.14131.
    PubMed     Text format     Abstract available
    
    
    
14. OKANO A, Ohana M
    Gastrointestinal: Improvement of refractory oral ulcer of Behcet's disease after eradication of Helicobacter pylori.
    J Gastroenterol Hepatol. 2018;33:560.
    PubMed     Text format    
    
    
    February 2018
15. PARK JC, Kim YJ, Kim EH, Lee J, et al
    Effectiveness of the polysaccharide hemostatic powder in non-variceal upper gastrointestinal bleeding: using propensity score matching.
    J Gastroenterol Hepatol. 2018 Feb 7. doi: 10.1111/jgh.14118.
    PubMed     Text format     Abstract available
    
    
    January 2018
16. ROBERTS-THOMSON IC
    THE RISE AND FALL OF PEPTIC ULCERATION: A DISEASE OF CIVILIZATION?
    J Gastroenterol Hepatol. 2018 Jan 10. doi: 10.1111/jgh.14090.
    PubMed     Text format     Abstract available
    
    
    December 2017
17. TAKAHASHI Y, Takeuchi T, Kojima Y, Nagami Y, et al
    Efficacy and safety of Helicobacter pylori eradication therapy immediately after endoscopic submucosal dissection.
    J Gastroenterol Hepatol. 2017 Dec 19. doi: 10.1111/jgh.14073.
    PubMed     Text format     Abstract available
    
    
    
18. MA J, Hiratsuka T, Etoh T, Akada J, et al
    Anti-proliferation effect of blue light-emitting diodes against antibiotic-resistant Helicobacter pylori.
    J Gastroenterol Hepatol. 2017 Dec 7. doi: 10.1111/jgh.14066.
    PubMed     Text format     Abstract available
    
    
    November 2017
19. XU MY, Ma JH, Yuan BS, Yin J, et al
    Association between helicobacter pylori infection and gallbladder diseases: a retrospective study.
    J Gastroenterol Hepatol. 2017 Nov 27. doi: 10.1111/jgh.14054.
    PubMed     Text format     Abstract available
    
    
    
20. MISHIRO T, Oka K, Kuroki Y, Takahashi M, et al
    Proton pump inhibitor alters oral microbiome in gastrointestinal tract of healthy volunteers.
    J Gastroenterol Hepatol. 2017 Nov 4. doi: 10.1111/jgh.14040.
    PubMed     Text format     Abstract available
    
    
    
21. KIM GU, Seo M, Song EM, Hwang SW, et al
    Association between the ulcer status and the risk of delayed bleeding after the endoscopic mucosal resection of colon.
    J Gastroenterol Hepatol. 2017;32:1846-1851.
    PubMed     Text format     Abstract available
    
    
    September 2017
22. MANABE N, Haruma K, Kusunoki H, Kamada T, et al
    Differences in Salivary Secretory Function between Patients with Erosive Esophagitis and Those with Nonerosive Reflux Disease.
    J Gastroenterol Hepatol. 2017 Sep 27. doi: 10.1111/jgh.14002.
    PubMed     Text format     Abstract available
    
    
    July 2017
23. MIN S, Kim N, Kwon YH, Hee R, et al
    RdxA, frxA and efflux pump in metronidazole-resistant Helicobacter pylori: their relation to clinical outcomes.
    J Gastroenterol Hepatol. 2017 Jul 27. doi: 10.1111/jgh.13906.
    PubMed     Text format     Abstract available
    
    
    May 2017
24. YANG EH, Cheng HC, Wu CT, Chen WY, et al
    Peptic ulcer bleeding patients with Rockall Scores >/= 6 are at risk of long-term ulcer rebleeding: a 3.5-year prospective longitudinal study.
    J Gastroenterol Hepatol. 2017 May 11. doi: 10.1111/jgh.13822.
    PubMed     Text format     Abstract available
    
    
    
25. KIM JH, Lim KS, Min YW, Lee H, et al
    Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis.
    J Gastroenterol Hepatol. 2017;32:1064-1070.
    PubMed     Text format     Abstract available
    
    
    January 2017
26. BATCHELOR R, Gilmartin JF, Kemp W, Hopper I, et al
    Dementia, cognitive impairment and proton pump inhibitor therapy - a systematic review.
    J Gastroenterol Hepatol. 2017 Jan 27. doi: 10.1111/jgh.13750.
    PubMed     Text format     Abstract available
    
    
    
27. EUSEBI LH, Rabitti S, Artesiani ML, Gelli D, et al
    PROTON PUMP INHIBITORS: RISKS OF LONG-TERM USE.
    J Gastroenterol Hepatol. 2017 Jan 16. doi: 10.1111/jgh.13737.
    PubMed     Text format     Abstract available
    
    
    
28. LEE YC, Lin JT
    Screening and Treating Helicobacter pylori Infection for Gastric Cancer Prevention on the Population Level.
    J Gastroenterol Hepatol. 2017 Jan 14. doi: 10.1111/jgh.13726.
    PubMed     Text format     Abstract available
    
    
    
29. GONG EJ, Choi KD, Jung HK, Youn YH, et al
    Quality of life, patient satisfaction, and disease burden in patients with gastroesophageal reflux disease with or without laryngopharyngeal reflux symptoms.
    J Gastroenterol Hepatol. 2017 Jan 3. doi: 10.1111/jgh.13716.
    PubMed     Text format     Abstract available
    
    
    
30. KONO Y, Kawano S, Takaki A, Shimomura Y, et al
    Oxidative stress controlling agents are effective for small intestinal injuries induced by non-steroidal anti-inflammatory drugs.
    J Gastroenterol Hepatol. 2017;32:136-145.
    PubMed     Text format     Abstract available
    
    
    December 2016
31. ZOU D, Goh KL
    An East Asian Perspective on the Interaction between Proton Pump Inhibitors and Clopidogrel.
    J Gastroenterol Hepatol. 2016 Dec 26. doi: 10.1111/jgh.13712.
    PubMed     Text format     Abstract available
    
    
    November 2016
32. ON ZX, Grant J, Shi Z, Taylor AW, et al
    The association between gastroesophageal reflux disease (GERD) with sleep quality, depression and anxiety in a cohort study of Australian men.
    J Gastroenterol Hepatol. 2016 Nov 11. doi: 10.1111/jgh.13650.
    PubMed     Text format     Abstract available
    
    
    October 2016
33. MINAKARI M, Badihian S, Jalalpour P, Sebghatollahi V, et al
    Etiology and outcome in patients with upper gastrointestinal bleeding: Study on 4747 patients in the central region of Iran.
    J Gastroenterol Hepatol. 2016 Oct 17. doi: 10.1111/jgh.13617.
    PubMed     Text format     Abstract available
    
    
    September 2016
34. JUNG SW, Kim SY, Choe JW, Hyun JJ, et al
    Standard and double dose intravenous proton pump inhibitor injections for prevention of bleeding after endoscopic resection.
    J Gastroenterol Hepatol. 2016 Sep 16. doi: 10.1111/jgh.13597.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Peptic Ulcer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: